Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CCR3 inhibition for ocular angiogenesis and macular degeneration

CCR3 inhibition for ocular angiogenesis and macular degeneration

US Patent 11345756 · Granted May 31, 2022

Estimated economic value: $15,617,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treating retinal degradation2025
Compositions and methods for treating retinal degradation2024
Compositions and methods for treating multiple sclerosis2024
Protection of cells from degeneration and treatment of geographic atrophy2024
Protection of cells from degeneration and treatment of geographic atrophy2023
Compositions and methods for treating retinal degradation2023
Compositions and methods for treating retinal degradation2023
Inflammasome inhibition for the treatment of Parkinson's disease, Alzheimer's di2022
Compositions and methods for treating retinal degradation2020
Methods of administering IgG1 antibodies and methods of suppressing angiogenesis2020
CCR3 inhibition for ocular angiogenesis and macular degeneration2019
Compositions and methods for treating retinal degradation2019